PART B MYTHBUSTER: Don't Miss Out On Extra Diabetes Reimbursement

Why This Topic Matters

Diabetes-related claims are frequent and can be denied or underpaid when screening, diagnosis ordering, or secondary reporting is handled incorrectly. Understanding the article helps readers recognize the general areas where diabetes coding and billing practices often create reimbursement problems.

Article Sections

1. Myth #1: Diabetes screening frequency and related claim elements

   Covers Medicare diabetes screening frequency, risk-factor documentation, and related billing components. Also addresses office testing, follow-up service reporting, and a screening-related diagnosis code.

2. Myth #2: Sequencing diabetes diagnosis codes with complications

   Reviews how diabetes diagnosis sequencing is discussed when complications or related conditions are present. The section focuses on the general question of when diabetes is reported first or second on a claim.

3. Myth #3: Long-term insulin reporting

   Addresses when insulin-use reporting is discussed for people with diabetes. The article distinguishes between broader diabetes categories without giving detailed coding instructions here.

4. Myth #4: Reporting diabetes and manifestation codes together

   Explains the relationship between diabetes diagnosis codes and associated manifestation coding on the claim form. It also notes form capacity changes and software limitations in broad terms.

5. Myth #5: Manifestation descriptors

   Discusses whether manifestation terminology must contain a specific word to be used with diabetes-related coding. The section includes broad examples of manifestation pairings.

6. Myth #6: Diabetes coding after pancreas transplant

   Covers post-transplant diabetes reporting considerations, including situations involving ongoing documentation or complications. It also notes a transplant-related status code.